Cargando…

Local control and possibility of tailored salvage after hypofractionated stereotactic radiotherapy of the cavity after brain metastases resection

In patients undergoing surgical resection of brain metastases, the risk of local recurrence remains high. Adjuvant whole brain radiation therapy (WBRT) can reduce the risk of local relapse but fails to improve overall survival. At two tertiary care centers in Germany, a retrospective study was perfo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bilger, Angelika, Bretzinger, Eva, Fennell, Jamina, Nieder, Carsten, Lorenz, Hannah, Oehlke, Oliver, Grosu, Anca‐Ligia, Specht, Hanno M., Combs, Stephanie E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2018
Materias:	Clinical Cancer Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6010898/ https://www.ncbi.nlm.nih.gov/pubmed/29745035 http://dx.doi.org/10.1002/cam4.1486

Ejemplares similares

Multicenter analysis of stereotactic radiotherapy of the resection cavity in patients with brain metastases
por: Combs, Stephanie E., et al.
Publicado: (2018)

Validation of the Graded Prognostic Assessment for Melanoma Using Molecular Markers (Melanoma-molGPA)
por: Nieder, Carsten, et al.
Publicado: (2018)

Local control and overall survival after frameless radiosurgery: A single center experience
por: Bilger, Angelika, et al.
Publicado: (2017)

Validation of the graded prognostic assessment for lung cancer with brain metastases using molecular markers (lung-molGPA)
por: Nieder, Carsten, et al.
Publicado: (2017)

Whole-brain irradiation with hippocampal sparing and dose escalation on metastases: neurocognitive testing and biological imaging (HIPPORAD) – a phase II prospective randomized multicenter trial (NOA-14, ARO 2015–3, DKTK-ROG)
por: Grosu, Anca-Ligia, et al.
Publicado: (2020)

Validation of the graded prognostic assessment for gastrointestinal cancers with brain metastases (GI-GPA)
por: Nieder, Carsten, et al.
Publicado: (2020)

The challenge of durable brain control in patients with brain-only metastases from breast cancer
por: Nieder, Carsten, et al.
Publicado: (2015)

Optimization of hippocampus sparing during whole brain radiation therapy with simultaneous integrated boost—tutorial and efficacy of complete directional hippocampal blocking
por: Popp, Ilinca, et al.
Publicado: (2022)

Hippocampus-Avoidance Whole-Brain Radiation Therapy Is Efficient in the Long-Term Preservation of Hippocampal Volume
por: Popp, Ilinca, et al.
Publicado: (2021)

Stereotactic radiosurgery (SRS) for brain metastases: a systematic review
por: Nieder, Carsten, et al.
Publicado: (2014)

Cyberknife(®) hypofractionated stereotactic radiosurgery (CK-hSRS) as salvage treatment for brain metastases
por: Telentschak, Sergej, et al.
Publicado: (2021)

Hypofractionated Stereotactic Radiotherapy as a Salvage Therapy for Recurrent High-Grade Gliomas: Single-Center Experience
por: Reynaud, Thomas, et al.
Publicado: (2018)

The Judicious Use of Stereotactic Radiosurgery and Hypofractionated Stereotactic Radiotherapy in the Management of Large Brain Metastases
por: Gutschenritter, Tyler, et al.
Publicado: (2020)

Hypofractionated stereotactic radiotherapy (HFSRT) versus single fraction stereotactic radiosurgery (SRS) to the resection cavity of brain metastases after surgical resection (SATURNUS): study protocol for a randomized phase III trial
por: Waltenberger, Maria, et al.
Publicado: (2023)

Normal tissue toxicity after small field hypofractionated stereotactic body radiation
por: Milano, Michael T, et al.
Publicado: (2008)

Radiosurgery or hypofractionated stereotactic radiotherapy after craniospinal irradiation in children and adults with medulloblastoma and ependymoma
por: Napieralska, Aleksandra, et al.
Publicado: (2018)

Hypofractionated stereotactic radiotherapy for large arteriovenous malformations
por: Wang, Huan-Chih, et al.
Publicado: (2012)

External Validation of the Graded Prognostic Assessment in Patients with Brain Metastases from Small Cell Lung Cancer
por: Nieder, Carsten, et al.
Publicado: (2022)

Low Incidence of Fatigue after Hypofractionated Stereotactic Body Radiation Therapy for Localized Prostate Cancer
por: Dash, Chiranjeev, et al.
Publicado: (2012)

Analysis of MRI Volumetric Changes After Hypofractionated Stereotactic Radiation Therapy for Benign Intracranial Neoplasms
por: Fega, Kathryn R., et al.
Publicado: (2018)

Brain metastases treated with hypofractionated stereotactic radiotherapy: 8 years experience after Cyberknife installation
por: Mengue, Laurence, et al.
Publicado: (2020)

The effects of PSA kinetics on the outcome of hypofractionated salvage radiotherapy for biochemical recurrence of prostate cancer after prostatectomy
por: Ishikawa, Hitoshi, et al.
Publicado: (2020)

Salvage Prostate Stereotactic Body Radiation Therapy After Definitive Cryoablation
por: Lischalk, Jonathan W., et al.
Publicado: (2021)

Development of a Score Predicting Survival after Palliative Reirradiation
por: Nieder, Carsten, et al.
Publicado: (2014)

Vestibular Schwannoma: Results of Hypofractionated Stereotactic Radiation Therapy
por: Pialat, Pierre-Marie, et al.
Publicado: (2021)

Einfluss einer adjuvanten Strahlentherapie im Vergleich zur „Early-salvage-Strahlentherapie“ auf die Letalität von Männern mit einem hohen Rezidivrisiko nach radikaler Prostatektomie wegen Prostatakarzinom
por: Spohn, Simon K. B., et al.
Publicado: (2021)

Short Survival Time after Palliative whole Brain Radiotherapy: Can We Predict Potential Overtreatment by Use of a Nomogram?
por: Nieder, Carsten, et al.
Publicado: (2017)

Excellent local control and tolerance profile after stereotactic body radiotherapy of advanced hepatocellular carcinoma
por: Gkika, Eleni, et al.
Publicado: (2017)

Risk factors for esophagitis after hypofractionated palliative (chemo) radiotherapy for non-small cell lung cancer
por: Nieder, Carsten, et al.
Publicado: (2020)

Hypofractionated Stereotactic Radiotherapy after Transarterial Chemoembolisation Failure in an Unresectable Hepatocellular Carcinoma: A Case Presentation
por: Fiorica, Francesco, et al.
Publicado: (2013)

Efficacy of PSMA ligand PET-based radiotherapy for recurrent prostate cancer after radical prostatectomy and salvage radiotherapy
por: Oehus, Ann-Kathrin, et al.
Publicado: (2020)

Unresectable hepatic PEComa: a rare malignancy treated with stereotactic body radiation therapy (SBRT) followed by complete resection
por: Kirste, Simon, et al.
Publicado: (2018)

Radiobiology of hypofractionated stereotactic radiotherapy: what are the optimal fractionation schedules?
por: Shibamoto, Yuta, et al.
Publicado: (2016)

Intracranial chordoma: radiosurgery, hypofractionated stereotactic radiotherapy and treatment outcomes
por: Napieralska, Aleksandra, et al.
Publicado: (2021)

Ultra-Hypofractionated Stereotactic Body Radiotherapy for Localized Prostate Cancer: Clinical Outcomes, Patterns of Recurrence, Feasibility of Definitive Salvage Treatment, and Competing Oncological Risk
por: Miszczyk, Marcin, et al.
Publicado: (2022)

Evaluation of efficacy and safety of robotic stereotactic body radiosurgery and hypofractionated stereotactic radiotherapy for vertebral metastases
por: Księżniak-Baran, Dorota, et al.
Publicado: (2015)

Definition and quality requirements for stereotactic radiotherapy: consensus statement from the DEGRO/DGMP Working Group Stereotactic Radiotherapy and Radiosurgery
por: Guckenberger, Matthias, et al.
Publicado: (2020)

Reproducibility and geometric accuracy of the fixster system during hypofractionated stereotactic radiotherapy
por: Lindvall, Peter, et al.
Publicado: (2008)

Hypofractionated stereotactic re-irradiation: treatment option in recurrent malignant glioma
por: Vordermark, Dirk, et al.
Publicado: (2005)

Hypofractionated stereotactic radiotherapy for brain metastases larger than three centimeters
por: Jiang, Xue-song, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_frmdt2gjvskvstap6tjpig5nmd